Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Updated Apple Health app uses FHIR to import patient health data

A growing number of hospitals are encouraging patients to keep and monitor personal health records Technology keeps the world connected like never before, offering access to a tremendous amount of data with just a simple touch. Much of that access is obtainable via mobile, and with each new app developed, more prospects and opportunities become…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

A growing number of hospitals are encouraging patients to keep and monitor personal health records

Technology keeps the world connected like never before, offering access to a tremendous amount of data with just a simple touch. Much of that access is obtainable via mobile, and with each new app developed, more prospects and opportunities become available.

For Apple, it’s always about making that data easier for users to see and to use. The company is now applying those principles to personal healthcare data.

The Apple Health App has the ability, when used with a wearable like the Apple watch, to log steps, monitor sleep patterns, and keep pace with the user’s heartbeat. A new update from Apple provides even more useful health-related information – the ability to import and view medical records, offering integration with a growing number of healthcare providers.

Ownership of data

Since the inception of Meaningful Use, patient rights’ advocates have pleaded with the government, major EHR vendors, and providers to make personal health records more easily – and freely – accessible. While a majority of providers have patient portals in place, the patient information is typically limited to lab results, appointment requests, or email communication with clinicians.

Apple Health presents a new frontier in personal patient data access that takes the next step that health app trailblazers like Microsoft HealthVault and Google Health were unable to make – providing patients with direct access to their PHR data stored in EHR databases via the FHIR API standard. (See: Frequently asked questions about FHIR APIs)

The user perspective

Alex Lin, a Corepoint Health solutions architect, recently had the opportunity to download his PHR from his healthcare provider via Apple Health:

“I was viewing Apple’s newest updates and noticed the beta testing for patient data, using FHIR. Because of the field I’m in, it was only natural to want to take part in the beta test. My healthcare provider was on the list, so I signed up.”

Authenticating the app was simple, Alex said.

“I needed to only enter the credentials for the patient portal provided by my physician.” After entering the information, the system begins to pull information from the EHR.

“Apple worked with FHIR for the beta to ensure the standard set. In fact, when the app displayed my information, it was tagged with this statement: ‘According to FHIR data.’”

Apple Health’s PHR functionality is somewhat limited, as it simply displays information from the patient’s last physician visit. The future, however, has many possibilities. Alex said:

“Steps and vitals tracked by an Apple Watch could be integrated into an EHR, which could be useful in the event of a medical emergency. This data could also inform physicians as to how patients are doing in prescribed weight loss programs, managing diseases like diabetes, or any number of things. But as of yet, there’s no integration functionality.”

Currently, the available data is in the form of resting data, with no notifications sent when something new is added. Alex also mentioned portability shortcomings.

“For example, if I go to one doctor, then follow up with another doctor, possibly one that is outside the network, the information can’t be exported. For continuity of care, I’d prefer to take my previous results digitally, not in a huge folder.”

Alex is optimistic the access provided by the technology can empowering patients.

“Just having the data could prompt people to care for themselves a little bit better,” he said.

Interoperability and integration

The ONC reported that as of 2015, 83% of healthcare providers had adopted the use of EHR data. However, even though they have the ability to create digital files, many don’t have the capability to handle FHIR requests for data, like those made by Apple Health. With an integration engine, these requests could be translated into a query of the EHR’s database and then securely returned to the patient via the app.

Putting integration to use in a patient channel has many advantages. But, what if a patient has multiple providers who aren’t in the same system?

Rather than dealing with multiple avenues of information, Apple’s new product could provide the ability to fully integrate patient data into a single app. While patient access to all their health records is just one of the possibilities on the Health app’s horizon, the next step has to include better interoperability.

To date, 39 health systems have already implemented the Apple Health App, and this number is expected to grow. Ultimately, it would be ideal for all Apple users to have the ability to view their PHR from every doctor and every healthcare organization on their phones or wearables via this app. However, there are still interoperability, integration, and compliance challenges to solve before this technology reaches its potential.

As an interoperability vendor and active participant in the creation of the FHIR standard, Corepoint Health products have the features needed to power innovations such as Apple Health. With Corepoint Integration Engine, the silos of different systems and providers can be mitigated, paving the way for for the entire healthcare community to share patient data with their patients. Explore all the features of our integration engine to see how it can play a role in patient data deliverability.

Read more at corepointhealth.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512